The decrease in the downstream signal molecules (such as p-FAK, p-AKT and p-ERK1/2) of integrin signaling confirmed the suppression of β1 integrin activation by F806 in ESCC cells. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.